142 related articles for article (PubMed ID: 17468923)
1. 48-Hour pH monitoring increases the risk of false positive studies when the capsule is prematurely passed.
Iqbal A; Lee YK; Vitamvas M; Oleynikov D
J Gastrointest Surg; 2007 May; 11(5):638-41. PubMed ID: 17468923
[TBL] [Abstract][Full Text] [Related]
2. Interference with daily activities and major adverse events during esophageal pH monitoring with bravo wireless capsule versus conventional intranasal catheter: a systematic review of randomized controlled trials.
Iluyomade A; Olowoyeye A; Fadahunsi O; Thomas L; Libend CN; Ragunathan K; Fenster J; Vignesh S
Dis Esophagus; 2017 Feb; 30(3):1-9. PubMed ID: 26952638
[TBL] [Abstract][Full Text] [Related]
3. 24 Versus 48-hour bravo pH monitoring.
Chander B; Hanley-Williams N; Deng Y; Sheth A
J Clin Gastroenterol; 2012 Mar; 46(3):197-200. PubMed ID: 21959323
[TBL] [Abstract][Full Text] [Related]
4. Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico.
Remes-Troche JM; Ibarra-Palomino J; Carmona-Sánchez RI; Valdovinos MA
Am J Gastroenterol; 2005 Nov; 100(11):2382-6. PubMed ID: 16279888
[TBL] [Abstract][Full Text] [Related]
5. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].
Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P
Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061
[TBL] [Abstract][Full Text] [Related]
6. Oesophageal pH monitoring using the Bravo catheter-free radio capsule.
Gillies RS; Stratford JM; Booth MI; Dehn TC
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):57-63. PubMed ID: 17206078
[TBL] [Abstract][Full Text] [Related]
7. Tolerability and clinical utility of the Bravo pH capsule in children.
Lacy BE; Edwards S; Paquette L; Weiss J; Kelley ML; Ornvold K
J Clin Gastroenterol; 2009 Jul; 43(6):514-9. PubMed ID: 19349903
[TBL] [Abstract][Full Text] [Related]
8. Day-to-day variability in acid reflux patterns using the BRAVO pH monitoring system.
Ahlawat SK; Novak DJ; Williams DC; Maher KA; Barton F; Benjamin SB
J Clin Gastroenterol; 2006 Jan; 40(1):20-4. PubMed ID: 16340628
[TBL] [Abstract][Full Text] [Related]
9. Impact of prolonged 48-h wireless capsule esophageal pH monitoring on diagnosis of gastroesophageal reflux disease and evaluation of the relationship between symptoms and reflux episodes.
Domingues GR; Moraes-Filho JP; Domingues AG
Arq Gastroenterol; 2011; 48(1):24-9. PubMed ID: 21537538
[TBL] [Abstract][Full Text] [Related]
10. The Bravo pH capsule system.
Kwiatek MA; Pandolfino JE
Dig Liver Dis; 2008 Mar; 40(3):156-60. PubMed ID: 18096447
[TBL] [Abstract][Full Text] [Related]
11. Wireless esophageal pH monitoring in children.
Gunnarsdóttir A; Stenström P; Arnbjörnsson E
J Laparoendosc Adv Surg Tech A; 2008 Jun; 18(3):443-7. PubMed ID: 18503382
[TBL] [Abstract][Full Text] [Related]
12. The Association Between Acidification Time on Wireless Motility Capsule and Gastroesophageal Reflux Disease.
Rodriguez SJ; Blackett JW; Jodorkovsky D
J Clin Gastroenterol; 2023 Oct; 57(9):886-889. PubMed ID: 36730661
[TBL] [Abstract][Full Text] [Related]
13. To Bravo or not? A comparison of wireless esophageal pH monitoring and conventional pH catheter to evaluate non-erosive gastroesophageal reflux disease in a multiracial Asian cohort.
Ang D; Teo EK; Ang TL; Ong J; Poh CH; Tan J; Fock KM
J Dig Dis; 2010 Feb; 11(1):19-27. PubMed ID: 20132427
[TBL] [Abstract][Full Text] [Related]
14. Comparison of esophageal acid exposure at 1 cm and 6 cm above the squamocolumnar junction using the Bravo pH monitoring system.
Pandolfino JE; Lee TJ; Schreiner MA; Zhang Q; Roth MP; Kahrilas PJ
Dis Esophagus; 2006; 19(3):177-82. PubMed ID: 16722995
[TBL] [Abstract][Full Text] [Related]
15. [Successful esophageal pH monitoring with Bravo capsule in patients with gastroesophageal reflux disease].
Valdovinos Díaz MA; Remes Troche JM; Ruiz Aguilar JC; Schmulson MJ; Valdovinos-Andraca F
Rev Gastroenterol Mex; 2004; 69(2):62-8. PubMed ID: 15757153
[TBL] [Abstract][Full Text] [Related]
16. Nonendoscopic transnasal placement of a wireless capsule for esophageal pH monitoring: feasibility, safety, and efficacy of a manometry-guided procedure.
Marchese M; Spada C; Iacopini F; Familiari P; Shah SG; Tringali A; Costamagna G
Endoscopy; 2006 Aug; 38(8):813-8. PubMed ID: 17001571
[TBL] [Abstract][Full Text] [Related]
17. Continuous 48-Hour Wireless Esophageal pH Monitoring in Children: Comparison Between Days 1 and 2.
Ravi A; Gunasekaran T; Berman J
J Pediatr Gastroenterol Nutr; 2016 Jan; 62(1):87-9. PubMed ID: 26196198
[TBL] [Abstract][Full Text] [Related]
18. Bravo (wireless) ambulatory esophageal pH monitoring: how do day 1 and day 2 results compare?
Bechtold ML; Holly JS; Thaler K; Marshall JB
World J Gastroenterol; 2007 Aug; 13(30):4091-5. PubMed ID: 17696227
[TBL] [Abstract][Full Text] [Related]
19. 24-h multichannel intraluminal impedance-pH monitoring may be an inadequate test for detecting gastroesophageal reflux in patients with mixed typical and atypical symptoms.
Han MS; Lada MJ; Nieman DR; Tschoner A; Peyre CG; Jones CE; Watson TJ; Peters JH
Surg Endosc; 2015 Jul; 29(7):1700-8. PubMed ID: 25398192
[TBL] [Abstract][Full Text] [Related]
20. Day-to-day discrepancy in Bravo pH monitoring is related to the degree of deterioration of the lower esophageal sphincter and severity of reflux disease.
Ayazi S; Hagen JA; Zehetner J; Banki F; Augustin F; Ayazi A; DeMeester SR; Oh DS; Sohn HJ; Lipham JC; DeMeester TR
Surg Endosc; 2011 Jul; 25(7):2219-23. PubMed ID: 21359906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]